A Study to Obtain Blood from Patients with Gammopathies

Overview

About this study

This study is being done to obtain blood from patients with gammopathies (the presence of abnormal proteins in the blood). The study doctors wish to test this blood to gain more information about the causes of gammopathy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Any patient with monoclonal, biclonal or triclonal gammopathy

Exclusion Criteria:

  • Patients with serious medical problems such as congestive heart failure. 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

S. Vincent Rajkumar, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20317432

Mayo Clinic Footer